Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial
Annals of Oncology, 09/18/09
Methy N et al. – Pathological parameters were not surrogate for OS or LC.
Methods- 742 eligible patients were randomly assigned to receive preoperative radiotherapy with or without concurrent chemotherapy
- Data analyses did not provide interpretable PTE measures for OS
- The highest PTE was reached by TRG, which explained 12% of the effect on local recurrence
- PTE explained by the CRM status was associated with a wide uncertainty (95% CI –81% to 105%), which does not exclude a potentially high degree of surrogacy
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
A blood-based biomarker panel for stratifying current risk for colorectal cancer
International Journal of Cancer, 11/25/09
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
Molecular Cancer, 11/24/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/24/09
Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway
Journal of Clinical Oncology, 11/24/09
XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk
BMC Cancer, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


